India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused by a sharp rise in platinum costs. The National Pharmaceutical Pricing Authority (NPPA) approved the one-time hike in public interest after supply disruptions affected hospitals across the country.

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces…

Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige…

Cancer patients in India face a severe shortage of platinum-based drugs due to rising costs and supply disruptions.

The Centre approves price hike for chemotherapy drugs Cisplatin and Carboplatin amid ongoing shortages in hospitals.

India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy agents, faced shortages due to rising raw…

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follows pleas from manufacturers citing…

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused by a sharp rise in platinum costs. The…